Huashan Hospital Affiliated to Fudan University

04580866

It is a core department of the National Center for Neurological Diseases, a National Key Clinical Specialty, and a National Key Discipline of the Ministry of Education; its neurology department is ranked among the top in the country according to Fudan University's Specialty Reputation List; it is a national referral center for neuroimmunological diseases, motor disorders, cognitive impairment, and cerebrovascular diseases; and it is comparable to the National Neurological Hospital in London, UK, and the neurology department of the Mayo Clinic in the United States.

Historical Origins and Spiritual Inheritance:

Founded in 1950 by Professor Zhang Yuanchang, the founder of neurology in my country, it is one of the earliest neurology departments established in the country. Professor Lü Chuanzhen led the team to lay the foundation for the neuroimmunological disease discipline and inherited the Huashan Neurology spirit of "identifying difficult cases, emphasizing precision, and protecting nerve function". It has seven sub-specialties: cerebrovascular diseases, neuroimmunological myopathy, motor disorders, cognitive disorders, epilepsy and sleep disorders, and neurogenetics, and is equipped with a neurology research institute.

Core business operational efficiency:

The hospital has a total of 269 beds across multiple campuses; it sees 350,000 to 400,000 outpatients annually and discharges approximately 20,000 patients annually; it possesses platforms for neuroelectrophysiology, neuromolecular imaging, and cerebrospinal fluid biomarker testing; it offers outpatient services for nearly 20 neurological diseases; it routinely offers multidisciplinary team (MDT) services for cerebrovascular diseases, cognitive impairment, myasthenia gravis, and Parkinson's disease; and it receives referrals from across the country for encephalitis of unknown cause, refractory myasthenia gravis, hereditary neuromuscular diseases, Alzheimer's disease, and complex cerebral small vessel disease.

Core strengths:

One of the most comprehensive neurology departments in the country in terms of subspecialty system; possessing a complete technology chain including **precision immunotherapy for neuroimmunology, molecular imaging + DBS multidisciplinary program control for Parkinson's disease, early diagnosis of Alzheimer's disease using biomarkers, integrated intravenous thrombolysis and interventional thrombectomy for acute stroke, and gene diagnosis of hereditary neurological diseases**; leading the country in the scale of specimen banks for myasthenia gravis and neuromuscular diseases; deep integration of neurology, surgery, imaging, and nuclear medicine to construct an integrated assessment system for complex central nervous system diseases.

Discipline Positioning and Global Benchmarking:

A national-level center for the diagnosis, treatment, quality control, talent training, and translational medicine of complex neurological diseases; benchmarked against the National Institution for Neurological Disorders in London; and compared to overseas centers that emphasize basic neurobiology, Huashan Neurology highlights standardized diagnosis and treatment of myasthenia gravis/autoimmune encephalitis in the Chinese population, a national collaborative management system for Parkinson's disease, a series of studies on cerebral small vessel disease, and localization verification of Alzheimer's disease biomarkers.

National Key Clinical Specialty; ranked No. 1 in the National Specialty Reputation Ranking for Dermatology for 14 consecutive years; National Referral Center for Complex and Severe Skin Diseases, Skin Immunological Diseases, Pigmentation Disorders, and Skin Tumors; benchmarked against the Department of Dermatology at Massachusetts General Hospital in the United States and the St. John's Institute of Dermatology in London in the United Kingdom.

The Department of Dermatology at Huashan Hospital, affiliated with Fudan University, was founded in 1929 by Professor Yang Guoliang, one of the founders of dermatology in my country. It is one of the earliest dermatology departments established in the country and was among the first institutions authorized to grant master's and doctoral degrees. The department has been approved as a National Key Clinical Specialty by the Ministry of Health, a Shanghai Municipal Key Clinical Discipline, and the Shanghai Institute of Dermatology. It is also the affiliated unit of the Shanghai Clinical Quality Control Center for Dermatology and the Shanghai Laser Therapy Quality Control Center. The current department director is Professor Wu Wenyu, and the deputy directors are Professor Xiang Leihong, Professor Luo Xiaoqun, Professor Lu Zhong, Professor Li Wei, and Professor Zhang Chengfeng.

Core business operational efficiency:

The department has over 30 attending physicians and associate chief physicians, and more than 100 doctors. It sees over 1.8 million outpatient and emergency visits annually, ranking first in the world for a single department. Approximately 60% of its patients come from other provinces, cities, and Hong Kong, Macau, and Taiwan. The ward has a total of 50 beds, and was the first to establish a laminar flow intensive care unit for dermatological diseases (6 beds). The success rate for rescuing critically ill patients reaches 98.7%. The department performs over 10,000 surgeries annually, and by 2025, the number of surgeries for malignant skin tumors has exceeded 31,000. Currently, it offers nearly 30 specialized outpatient clinics for atopic dermatitis, psoriasis, vitiligo, hair loss, acne, autoimmune eczema, urticaria, photosensitive skin diseases, lupus erythematosus, fungal skin diseases, skin tumors, and rare genetic skin diseases. It also has 30 subspecialties, including laser treatment, surgery, vitiligo treatment, and hair transplantation centers.

Discipline Positioning and Core Strengths:

The department has been ranked first in the Fudan University's Best Dermatology Departments in China for 15 consecutive years, making it a nationally and internationally recognized center for dermatological diagnosis and treatment. Its core advantages can be summarized as a four-dimensional integration of "nearly a century of academic heritage × the world's largest single-specialty outpatient scale × international leadership in hair medicine and pigmentary disorders × original breakthroughs in tissue-engineered skin transplantation." Professor Yang Guoliang, the discipline's founder, is one of the pioneers of dermatology in my country. Through nearly a century of accumulation, Huashan Dermatology Department has developed unique academic advantages in the diagnosis and treatment of complex and critical illnesses, hair medicine, pigmentary disorders, and skin tumor surgery. Several members of the department have served as chairpersons and vice chairpersons of national academic organizations. In 2024, the department was among the first to obtain the qualification of a pilot drug clinical trial institution for the review and approval of optimized innovative drug clinical trials.